Effects of four different hormone replacement therapy regimens on certain cardiovascular risk factors

Turkish Journal of Medical Sciences

Volumn 30, Issue 5, 2000, Pages 469-473

  Malatyalioglu, E ^a   Kokcu, A ^a   Yanik, F F ^a   Alper, T ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Cardiovascular disease; Estrogen; Menopause; Progesterone; Tibolone

Indexed keywords

CONJUGATED ESTROGEN; CYPROTERONE ACETATE PLUS ESTRADIOL VALERATE; ESTRADIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TIBOLONE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; RISK FACTOR;

EID: 0033791457     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins
2. Estrogens: Effects on the cardiovascular tree
3. HRT, plasma risk factors and cardiovascular disease
4. HRT mechanisms of action: Carbohydrates
5. Hormone replacement therapy and cardiovascular disease
6. Mechanisms whereby oestrogens influence arterial health
7. Estrogen and cardiovascular disease
8. Metabolic effects of estrogens and progestins
9. Tibolone: Influence on markers of cardiovascular disease
10. Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in cohort of French women
11. Transdermal oestradiol and cardiovascular risk factors
12. Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration alone or in cyclic association with utrogestan in menopausal women
13. Effects of estrogen and progesterone on plasma lipoprotein and experimental atherosclerosis in the baboon
14. Long-term effects of Org OD 14 in menopausal women on lipid metabolism
15. Changes in lipid and hemostatic parameters induced by tibolone treatment
16. The route of administration influences the effect of estrogen on insulin sensitivity in post-menopausal women
17. Hormone replacement therapy and the cardiovascular system. Nonlipid effects